Managing ADHD Medication Access: Shortages, Refills & Logistics

Last reviewed: June 2026. This is an evolving situation — shortage status, DEA quotas, and which formulations are short all change frequently. Check the live FDA and ASHP shortage databases before relying on any specific availability claim.

Scope: This page focuses on the United States, where ADHD stimulants are federally controlled (Schedule II) — which drives most of the refill and transfer rules below. Other countries have different laws, supply, and available medications; if you’re outside the US, verify the rules and resources locally.

Not medical advice. Nothing here replaces your prescriber or pharmacist. Wherever a medication is named, the action is always “ask your prescriber or pharmacist.” This page does not recommend drugs, doses, or changes.

Why this keeps happening

If you’ve been unable to fill your prescription, it’s not your fault and you’re not imagining it. The US has had an ongoing, well-documented shortage of ADHD stimulants since October 2022, when the FDA first listed amphetamine mixed salts (the active ingredient in Adderall) as in shortage. As of this review (June 2026), the FDA database still lists amphetamine mixed salts (immediate- and extended-release) in shortage, with intermittent methylphenidate shortages too — but status changes often, so check the live FDA database for the current picture. Availability varies a lot by location, dose, and formulation.

It’s a stubborn shortage because several causes stack up:

DEA production quotas. Stimulants are Schedule II, so the DEA sets an annual national ceiling on how much active ingredient can be made. Advocates argue the quotas have lagged real demand. The DEA has raised some quotas in response (it increased certain amphetamine-related quotas for 2026) — but not every shortage-relevant ingredient, and supply hasn’t fully caught up. Current figures are in the DEA’s Federal Register quota notices.
Manufacturing and ingredient issues. Multiple generic makers have reported backorders and sourcing problems; when one falls behind, others can’t always absorb demand — partly because their output is quota-capped too.
Rising demand. ADHD diagnoses and prescriptions have increased across age groups, including adults.
Controlled-substance rules amplify everything. Schedule II limits how prescriptions move and how far ahead you can fill, so the system has little slack to absorb a disruption.

Outlook: supply has been improving unevenly, but availability remained inconsistent through much of 2026 and forecasts vary. Treat any “the shortage is over” claim with caution, and rely on the live FDA/ASHP databases below rather than predictions.

When your medication is unavailable

No single trick fixes a shortage, but these are the levers people actually use. The recurring themes in expert guidance: persistence, flexibility, and planning ahead.

Pharmacy-hunting

Call ahead before you’re out — phone first; don’t drive around.
Ask for the pharmacist and ask two things: do you have it now, and when does your next distributor order arrive?
Call widely — chains and independent pharmacies (independents are often overlooked and sometimes have stock).
Pharmacies generally won’t reserve a controlled substance over the phone, so confirm before sending a script.
Build a relationship with a local pharmacy — being a known, courteous regular genuinely helps.

Ask your prescriber about options (ask — don’t self-adjust)

Your prescriber may switch you to something in stock. Whether any option fits you is a clinical decision. Described neutrally, with no dosing:

A different formulation of the same drug (IR vs ER/XR, or a different brand/generic).
A different stimulant class (methylphenidate- vs amphetamine-based), which can have different supply at any given moment.
Less-common forms (liquids, chewables, patches) sometimes in stock when standard tablets aren’t.
Non-stimulant medications — your prescriber might raise options like atomoxetine, viloxazine, guanfacine, clonidine, or bupropion. These aren’t controlled substances (so they aren’t subject to the same shortage/refill constraints) and may take longer to show benefit. Appropriateness and any switch are entirely your prescriber’s call.

The controlled-substance rules that make this hard

Knowing the rules helps you plan. (This is the federal baseline; states often add stricter rules, so your pharmacist is the authority for your situation.)

No refills on Schedule II. Each fill needs a new prescription — stimulants can’t be “refilled.” Federal law does not set a specific expiration period for a Schedule II prescription (the 6-month rule people cite is the refill window for Schedule III–IV drugs). But your state, insurer, and pharmacy may impose stricter limits, so don’t assume an older script is still fillable — check with your pharmacist.
Limited early fills. You generally can’t fill a Schedule II prescription far in advance — but exactly how early you can request, transmit, and fill the next one varies by state, insurer, pharmacy, and your prescription’s instructions. Ask your prescriber and pharmacist what’s allowed for you, and plan enough runway to hunt if there’s a problem.
Transfers are limited. Since August 2023, an electronic Schedule II prescription can be transferred between pharmacies for an initial fill once, at the patient’s request — pharmacist-to-pharmacist. In practice, it’s often easier to ask your prescriber to send a fresh e-script to a pharmacy that has stock.
~30-day supply norm, which is why this becomes a monthly logistics task.

Mail-order, insurance & cost tools

Mail-order pharmacies (often via insurance) can sometimes supply when retail can’t, but Schedule II timing rules make them less flexible in a pinch — plan further ahead.
Insurance formularies / prior authorization can force a specific brand or generic; your prescriber’s office can sometimes request an exception.
Cost/discount tools — GoodRx, SingleCare, and manufacturer copay/patient-assistance programs for brand-name drugs — can lower cost and widen which pharmacies are realistic. (Discount cards usually can’t be combined with insurance, and acceptance varies by pharmacy. Program terms change — check the official source.)

Coping without medication during a gap

A gap is hard, and it’s not a personal failure. ADHD is brain-based; if going without your medication makes work and daily tasks harder, that’s the medication doing its job — not a lack of effort. Be kind to yourself and lower the bar where you can.

Non-medication supports won’t replace medication, but they can take some of the edge off:

Externalize everything. Get tasks out of your head and into a visible system — sticky notes, whiteboards, alarms, reminders. Don’t rely on working memory during a gap.
Shrink and structure the day. Postpone non-urgent high-focus tasks; break what’s left into very small steps; use timers for short focused sprints.
Body doubling. Working alongside someone — in person or on a video call — helps many people start and stay on tasks.
Protect sleep, movement, and food. Consistent sleep, regular exercise, and not skipping meals all support attention and mood — they matter more during a gap, not less.
Lean on routines and anchors (same wake time, same start-of-work ritual) to cut the number of decisions you face.
Tell the people who need to know. A heads-up (“my meds are short this week, I may be slower on X”) can lower the stakes and buy flexibility.

Safety note — don’t buy stimulants from non-pharmacy sources

It’s understandable to feel desperate during a gap. But buying “Adderall” or other stimulants from online sites that don’t require a prescription, social-media sellers, or any non-pharmacy source is genuinely dangerous. The DEA has warned that illegal online pharmacies ship counterfeit pills made with fentanyl and methamphetamine, disguised as real medication — and people have died. These sites are built to look legitimate. The only reliably safe medication is one prescribed by a licensed provider and dispensed by a real, licensed pharmacy. If you’re at the end of your options, keep working your prescriber and pharmacist, use the resources below, and consider telehealth through licensed providers.

Organizations & resources

CHADD — major ADHD nonprofit; practical shortage guidance and support.
ADDA — the leading nonprofit focused specifically on adults with ADHD; peer support and resources.
FDA Drug Shortages — official current US shortage status (searchable database — search by active-ingredient name, e.g. “amphetamine”).
ASHP Drug Shortages — pharmacist-oriented tracker, often more granular than FDA.
DEA — Illegal Online Pharmacies — why to avoid non-pharmacy sources.
Manufacturer assistance — each drug’s maker runs its own copay/patient-assistance program; search the official maker’s site for your specific medication.

Contribute to This Page

Know a working strategy, a patient-assistance program, or a correction — especially anything time-sensitive about the current shortage? See How to Contribute.